Kotra Industries Berhad (0002.KL)
MYR 4.33
(-1.59%)
MYR 4.33
(-1.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 63.54 Million MYR | 7.34% |
| 2022 | 59.2 Million MYR | 7.62% |
| 2021 | 55.01 Million MYR | 19.27% |
| 2020 | 46.12 Million MYR | -27.23% |
| 2019 | 63.38 Million MYR | -14.67% |
| 2018 | 74.28 Million MYR | -17.07% |
| 2017 | 89.57 Million MYR | -18.6% |
| 2016 | 110.04 Million MYR | -10.13% |
| 2015 | 122.45 Million MYR | -7.41% |
| 2014 | 132.25 Million MYR | -13.64% |
| 2013 | 153.14 Million MYR | -1.4% |
| 2012 | 155.32 Million MYR | -0.04% |
| 2011 | 155.38 Million MYR | 6.05% |
| 2010 | 146.52 Million MYR | 4.83% |
| 2009 | 139.77 Million MYR | 32.54% |
| 2008 | 105.45 Million MYR | 273.49% |
| 2007 | 28.23 Million MYR | 97.68% |
| 2006 | 14.28 Million MYR | 10.88% |
| 2005 | 12.88 Million MYR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 63.54 Million MYR | 21.0% |
| 2023 Q2 | 51.14 Million MYR | -10.2% |
| 2023 Q3 | 52.51 Million MYR | 2.69% |
| 2023 FY | 59.33 Million MYR | 0.22% |
| 2023 Q1 | 56.95 Million MYR | -3.79% |
| 2022 FY | 59.2 Million MYR | 7.62% |
| 2022 Q4 | 59.2 Million MYR | 17.52% |
| 2022 Q3 | 50.37 Million MYR | -13.2% |
| 2022 Q2 | 58.04 Million MYR | -10.48% |
| 2022 Q1 | 64.83 Million MYR | 17.86% |
| 2021 Q2 | 45.07 Million MYR | -7.99% |
| 2021 Q4 | 55.01 Million MYR | 37.67% |
| 2021 Q3 | 39.96 Million MYR | -11.34% |
| 2021 FY | 55.01 Million MYR | 19.27% |
| 2021 Q1 | 48.98 Million MYR | 6.21% |
| 2020 Q3 | 50.21 Million MYR | -0.51% |
| 2020 FY | 46.12 Million MYR | -27.23% |
| 2020 Q1 | 58.58 Million MYR | -7.58% |
| 2020 Q2 | 50.47 Million MYR | -13.84% |
| 2020 Q4 | 46.12 Million MYR | -8.15% |
| 2019 Q4 | 63.38 Million MYR | -1.56% |
| 2019 FY | 63.38 Million MYR | -14.67% |
| 2019 Q1 | 66.26 Million MYR | -10.8% |
| 2019 Q2 | 64.36 Million MYR | -2.87% |
| 2019 Q3 | 64.39 Million MYR | 0.05% |
| 2018 Q4 | 74.28 Million MYR | -6.3% |
| 2018 FY | 74.28 Million MYR | -17.07% |
| 2018 Q3 | 79.27 Million MYR | -4.65% |
| 2018 Q2 | 83.13 Million MYR | -4.29% |
| 2018 Q1 | 86.86 Million MYR | -3.02% |
| 2017 FY | 89.57 Million MYR | -18.6% |
| 2017 Q4 | 89.57 Million MYR | -10.44% |
| 2017 Q1 | 98.27 Million MYR | -10.69% |
| 2017 Q2 | 96.66 Million MYR | -1.63% |
| 2017 Q3 | 100.01 Million MYR | 3.46% |
| 2016 Q4 | 110.04 Million MYR | -5.19% |
| 2016 FY | 110.04 Million MYR | -10.13% |
| 2016 Q1 | 114.42 Million MYR | -6.56% |
| 2016 Q2 | 116.65 Million MYR | 1.96% |
| 2016 Q3 | 116.06 Million MYR | -0.51% |
| 2015 Q3 | 129 Million MYR | -1.43% |
| 2015 Q4 | 122.45 Million MYR | -5.08% |
| 2015 Q2 | 130.87 Million MYR | -1.19% |
| 2015 Q1 | 132.44 Million MYR | 0.15% |
| 2015 FY | 122.45 Million MYR | -7.41% |
| 2014 Q4 | 132.25 Million MYR | -8.46% |
| 2014 FY | 132.25 Million MYR | -13.64% |
| 2014 Q2 | 142.55 Million MYR | -3.79% |
| 2014 Q1 | 148.17 Million MYR | -3.25% |
| 2014 Q3 | 144.47 Million MYR | 1.35% |
| 2013 Q2 | 155.41 Million MYR | 2.05% |
| 2013 Q3 | 162.13 Million MYR | 4.32% |
| 2013 Q4 | 153.14 Million MYR | -5.54% |
| 2013 FY | 153.14 Million MYR | -1.4% |
| 2013 Q1 | 152.29 Million MYR | -1.95% |
| 2012 Q2 | 146.69 Million MYR | -4.81% |
| 2012 Q4 | 155.32 Million MYR | 4.8% |
| 2012 FY | 155.32 Million MYR | -0.04% |
| 2012 Q1 | 154.1 Million MYR | -0.82% |
| 2012 Q3 | 148.2 Million MYR | 1.03% |
| 2011 Q4 | 155.38 Million MYR | 1.36% |
| 2011 Q3 | 153.29 Million MYR | -1.21% |
| 2011 FY | 155.38 Million MYR | 6.05% |
| 2011 Q2 | 155.17 Million MYR | 0.0% |
| 2010 FY | 146.52 Million MYR | 4.83% |
| 2010 Q3 | 146.67 Million MYR | 0.0% |
| 2010 Q4 | 146.52 Million MYR | -0.1% |
| 2009 Q4 | 139.77 Million MYR | 0.0% |
| 2009 FY | 139.77 Million MYR | 32.54% |
| 2008 FY | 105.45 Million MYR | 273.49% |
| 2007 FY | 28.23 Million MYR | 97.68% |
| 2006 FY | 14.28 Million MYR | 10.88% |
| 2005 FY | 12.88 Million MYR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Duopharma Biotech Berhad | 658.01 Million MYR | 90.342% |